BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. The.
DATA MINING IN PROGRAM INTEGRITY AND FRAUD CONTROL PHARMACEUTICAL REG AND COMPLIANCE CONGRESS 2008 Jim Sheehan New York Medicaid Inspector General (518)
How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.
1 International Clinical Trials: Current Issues in Clinical Trial Regulation and Future Reforms: EU, US, and Beyond: a European perspective International.
FDAAA Title VIII ( PL 110-85, Section 801) Expanded Clinical Trials Registry and Results Database Status Report on Implementation Theresa Toigo Director,
© Hogan & Hartson LLP. All rights reserved. How We Get to Where We Want to Be – Managing GCP Inspections Pre-Approval Robert F. Church, Partner Hogan &
Emerging Issues in Latin America The International Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum Brussels, June 6-7, 2007.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED Presented by Raymond A. Bonner Nathan C. Sheers SIDLEY AUSTIN BROWN & WOOD, LLP Washington,
CCC Executive Briefing: PRT Efficiency - Turbo Charging Commercial and Compliance Effectiveness
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Personalized Medicine - Implications for Medical Technology Gerald J.
Medical Device Regulatory, Reimbursement and Compliance Congress Randel E. Richner, BSN, MPH President, Founder March 27, 2008 Value-Based Pricing: The.
Managing Sales & Marketing Compliance With Technology The Seventh Annual Pharmaceutical Regulatory and Compliance Congress November 9 th 2006 Bill Van.